Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

NCT03187795 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injuries
Urinary Bladder, Neurogenic

Interventions

DRUG: Oxybutynin Chloride IR
DRUG: Mirabegron

Sponsor

Kessler Foundation

Collaborators

[object Object]